AsuraGen, a US-based diagnostic development company and genomic services provider, has raised $5m of a planned $10m round from a consortium apparently including local drugs maker Merck, accoridng to a regulatory filing.
AsuraGen, a US-based diagnostic development company and genomic services provider, has raised $5m of a planned $10m round from a consortium apparently including local drugs maker Merck, accoridng to a regulatory filing.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
